Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 11, Issue 5, Pages 841-850
Publisher
Informa Healthcare
Online
2012-07-28
DOI
10.1517/14740338.2012.708732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation
- (2012) W. D. Chey et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Patient-Reported Outcomes for Irritable Bowel Syndrome Are Associated With Patients' Severity Ratings of Gastrointestinal Symptoms and Psychological Factors
- (2011) Jeffrey Lackner et al. Clinical Gastroenterology and Hepatology
- Lubiprostone for the Treatment of Adults with Constipation and Irritable Bowel Syndrome
- (2011) Ron Schey et al. DIGESTIVE DISEASES AND SCIENCES
- Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation
- (2011) Anthony J. Lembo et al. DIGESTIVE DISEASES AND SCIENCES
- Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
- (2011) William D. Chey et al. Gut and Liver
- Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study
- (2011) S. Fukudo et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation
- (2010) J. F. JOHANSON et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
- (2010) Robert C De Lisle et al. BMC GASTROENTEROLOGY
- Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
- (2009) Misa Mizumori et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation
- (2009) Charles F. Barish et al. DIGESTIVE DISEASES AND SCIENCES
- Lubiprostone: Clinical applications beyond constipation
- (2009) Shailendra Kapoor WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies
- (2008) D. A. DROSSMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice
- (2008) Kelvin D. MacDonald et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon
- (2008) A K Bassil et al. BRITISH JOURNAL OF PHARMACOLOGY
- CLC Chloride Channels and Transporters: From Genes to Protein Structure, Pathology and Physiology
- (2008) Thomas J. Jentsch CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine
- (2008) Adam J Moeser et al. WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started